Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Morpholino oligonucleotides are stable, uncharged, water-soluble molecules that bind to complementary sequences of RNA, thereby inhibiting mRNA processing, read-through, and protein binding at those sites. Morpholinos are typically used to inhibit translation of mRNA, splicing of pre-mRNA, and maturation of miRNA, although they can also inhibit other interactions between biological macromolecules and RNA. Morpholinos are effective, specific, and lack non-antisense effects. They work in any cell that transcribes and translates RNA. However, unmodified Morpholinos do not pass well through plasma membranes and must therefore be delivered into the nuclear or cytosolic compartment to be effective. Morpholinos form stable base pairs with complementary nucleic acid sequences but apparently do not bind to proteins to a significant extent. They are not recognized by proteins and do not undergo protein-mediated catalysis; nor do they mediate RNA cleavage by RNase H or the RISC complex. This work focuses on techniques and background for using Morpholinos.
Aboul-ela,
Base-base mismatches. Thermodynamics of double helix formation for dCA3XA3G + dCT3YT3G (X, Y = A,C,G,T).
1985, Pubmed
Aboul-ela,
Base-base mismatches. Thermodynamics of double helix formation for dCA3XA3G + dCT3YT3G (X, Y = A,C,G,T).
1985,
Pubmed
Alonso,
Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers.
2005,
Pubmed
Bruno,
Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.
2004,
Pubmed
Cerda,
Electroporation of DNA, RNA, and morpholinos into zebrafish embryos.
2006,
Pubmed
Cheong,
Solution structure of an unusually stable RNA tetraplex containing G- and U-quartet structures.
1992,
Pubmed
Choi,
Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430.
2007,
Pubmed
Deas,
Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.
2005,
Pubmed
Draper,
Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: a quantifiable method for gene knockdown.
2001,
Pubmed
,
Xenbase
Ekker,
Morphants: a new systematic vertebrate functional genomics approach.
2000,
Pubmed
Ekker,
Morphant technology in model developmental systems.
2001,
Pubmed
Enterlein,
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.
2006,
Pubmed
Geller,
Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.
2005,
Pubmed
Giles,
Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA.
1999,
Pubmed
Hayashi,
A sensitive and reproducible assay to measure the activity of glucosylceramide synthase and lactosylceramide synthase using HPLC and fluorescent substrates.
2005,
Pubmed
He,
Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
2004,
Pubmed
He,
Pharmacokinetics in mice of four oligomer-conjugated polymers for amplification targeting.
2003,
Pubmed
Heasman,
Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach.
2000,
Pubmed
,
Xenbase
Henderson,
Reaction of diethyl pyrocarbonate with nucleic acid components. Adenosine-containing nucleotides and dinucleoside phosphates.
1973,
Pubmed
Howard,
Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides.
2004,
Pubmed
Hudziak,
Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation.
1996,
Pubmed
Jubin,
Optimizing electroporation conditions for intracellular delivery of morpholino antisense oligonucleotides directed against the hepatitis C virus internal ribosome entry site.
2005,
Pubmed
Jubin,
Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding.
2000,
Pubmed
Kamachi,
Quantitative assessment of the knockdown efficiency of morpholino antisense oligonucleotides in zebrafish embryos using a luciferase assay.
2008,
Pubmed
Kang,
Stacking interactions of ApA analogues with modified backbones.
1992,
Pubmed
Khokha,
Techniques and probes for the study of Xenopus tropicalis development.
2002,
Pubmed
,
Xenbase
Kimmel,
Cell lineage of zebrafish blastomeres. II. Formation of the yolk syncytial layer.
1985,
Pubmed
Kimmel,
Cell lineage of zebrafish blastomeres. III. Clonal analyses of the blastula and gastrula stages.
1985,
Pubmed
Kinney,
Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers.
2005,
Pubmed
Kloosterman,
Substrate requirements for let-7 function in the developing zebrafish embryo.
2004,
Pubmed
Kloosterman,
Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development.
2007,
Pubmed
Kos,
Methods for introducing morpholinos into the chicken embryo.
2003,
Pubmed
Lebedeva,
Antisense oligonucleotides: promise and reality.
2001,
Pubmed
Li,
Design and synthesis of dendritic molecular transporter that achieves efficient in vivo delivery of morpholino antisense oligo.
2008,
Pubmed
Liu,
Cytosine residues influence kidney accumulations of 99mTc-labeled morpholino oligomers.
2002,
Pubmed
Liu,
The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice.
2002,
Pubmed
Mang'era,
Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
2001,
Pubmed
Masaki,
Smad1 protects cardiomyocytes from ischemia-reperfusion injury.
2005,
Pubmed
McCaffrey,
A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
2003,
Pubmed
McClorey,
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.
2006,
Pubmed
Mellitzer,
Spatial and temporal 'knock down' of gene expression by electroporation of double-stranded RNA and morpholinos into early postimplantation mouse embryos.
2002,
Pubmed
Melton,
Combinatorial control of signal-induced exon repression by hnRNP L and PSF.
2007,
Pubmed
Monga,
Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification.
2003,
Pubmed
Morcos,
Achieving efficient delivery of morpholino oligos in cultured cells.
2001,
Pubmed
Morcos,
Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos.
2007,
Pubmed
Moulton,
Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
2004,
Pubmed
Moulton,
Peptide-assisted delivery of steric-blocking antisense oligomers.
2003,
Pubmed
Nasevicius,
Effective targeted gene 'knockdown' in zebrafish.
2000,
Pubmed
Nelson,
Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
2005,
Pubmed
Neuman,
Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth.
2004,
Pubmed
Neuman,
Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers.
2005,
Pubmed
Nutt,
Comparison of morpholino based translational inhibition during the development of Xenopus laevis and Xenopus tropicalis.
2001,
Pubmed
,
Xenbase
Partridge,
A simple method for delivering morpholino antisense oligos into the cytoplasm of cells.
1996,
Pubmed
Prasadan,
Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas.
2002,
Pubmed
Riedel-Kruse,
Synchrony dynamics during initiation, failure, and rescue of the segmentation clock.
2007,
Pubmed
Sazani,
Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs.
2001,
Pubmed
Sazani,
Systemically delivered antisense oligomers upregulate gene expression in mouse tissues.
2002,
Pubmed
Scacheri,
Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells.
2004,
Pubmed
Schmajuk,
Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
1999,
Pubmed
Stancheva,
A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.
2003,
Pubmed
,
Xenbase
Stein,
A specificity comparison of four antisense types: morpholino, 2'-O-methyl RNA, DNA, and phosphorothioate DNA.
1997,
Pubmed
Stein,
Inhibition of Vesivirus infections in mammalian tissue culture with antisense morpholino oligomers.
2001,
Pubmed
Stirchak,
Uncharged stereoregular nucleic acid analogs: 2. Morpholino nucleoside oligomers with carbamate internucleoside linkages.
1989,
Pubmed
Summerton,
Endo-Porter: a novel reagent for safe, effective delivery of substances into cells.
2005,
Pubmed
Summerton,
Morpholino antisense oligomers: design, preparation, and properties.
1997,
Pubmed
,
Xenbase
Summerton,
Morpholino antisense oligomers: the case for an RNase H-independent structural type.
1999,
Pubmed
Suwanmanee,
Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder.
2002,
Pubmed
Takahashi,
Manipulating gene expressions by electroporation in the developing brain of mammalian embryos.
2002,
Pubmed
Thummel,
Inhibition of zebrafish fin regeneration using in vivo electroporation of morpholinos against fgfr1 and msxb.
2006,
Pubmed
Tidd,
Expression of c-myc is not critical for cell proliferation in established human leukemia lines.
2001,
Pubmed
Tucker,
Antisense knockdown of the beta1 integrin subunit in the chicken embryo results in abnormal neural crest cell development.
2004,
Pubmed
Tyson-Capper,
Novel targeting of cyclooxygenase-2 (COX-2) pre-mRNA using antisense morpholino oligonucleotides directed to the 3' acceptor and 5' donor splice sites of exon 4: suppression of COX-2 activity in human amnion-derived WISH and myometrial cells.
2006,
Pubmed
Warfield,
Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
2006,
Pubmed
Yen,
Exogenous control of mammalian gene expression through modulation of RNA self-cleavage.
2004,
Pubmed
Youngblood,
Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
2007,
Pubmed
van den Born,
Antiviral activity of morpholino oligomers designed to block various aspects of Equine arteritis virus amplification in cell culture.
2005,
Pubmed
